Friday, May 31, 2013

Drug Discovery@nature.com 31 May 2013

Drug Discovery
TABLE OF CONTENTS

31 May 2013

News
Analysis
Research Highlights
Research & Reviews
Careers


Nature Reviews Drug Discovery is on Twitter

Advertisement
Nature Structural & Molecular Biology
FOCUS ON EPIGENETIC DYNAMICS

This Focus explores emerging themes and the functional implications of epigenetic dynamics.

Access the Focus for FREE at:
www.nature.com/nsmb/focus/epigeneticdynamics

This Focus is freely available thanks to support from
Active Motif
 

News

Top

Immunotherapy's cancer remit widens
doi:10.1038/497544a
Combination therapies hold great promise, but at what cost?
Full Text

Studies cast doubt on cancer drug as Alzheimer's treatment
doi:10.1038/nature.2013.13058
Independent researchers fail to replicate bexarotene results.
Full Text

Scientists discover molecular trigger for itch
doi:10.1038/nature.2013.13061
Identification of distinct neural circuit distinguishes the sensation from pain.
Full Text

New avian flu readily transmits in key animal model
doi:10.1038/nature.2013.13062
Emerging H7N9 virus easily jumps between ferrets even though there is no evidence for human-to-human transmission.
Full Text

Analysis

Top

IRS audit for tumors
doi:10.1038/scibx.2013.478
A partnership has discovered small molecules that target insulin receptor substrates 1 and 2, which sit downstream of the cancer-associated insulin-like growth factor-1 receptor. The compounds have been licensed to NovoTyr.
Full Text

Commercial prospects for genomic sequencing technologies
doi:10.1038/nrd4006
This article analyses the evolution of the market for genomic sequencing technologies in the light of major reductions in sequencing costs and time, and the growth in potential pharmacogenomics applications.
Full Text

Research Highlights

Top

Tumour vaccination: Devil in the details of adjuvant choice
doi:10.1038/nrd4014
The widespread use of incomplete Freud's adjuvant in cancer vaccination protocols might be to blame for lack of effectiveness.
Full Text

Kinase inhibitors: Double duty
doi:10.1038/nrd4011
A new mechanism of action for ATP-competitive kinase inhibitors, an important class of anticancer agents, could have implications for the way these inhibitors are used in the clinic.
Full Text

Infectious diseases: Novel agents fight flu infection
doi:10.1038/nrd4013
Two papers have recently identified novel inhibitors of influenza virus replication that might overcome limitations of existing drugs.
Full Text

Research & Reviews

Top

Platforms for antibiotic discovery
doi:10.1038/nrd3975
Re-establishing effective platforms for antibiotic discovery is crucial for combating antibiotic resistance. This article discusses the lessons learned from the golden era of antibiotic discovery, and proposes strategies to create new platforms or revitalize old ones.
Full Text

Implementing personalized cancer genomics in clinical trials
doi:10.1038/nrd3979
This article explores how genomic information can be used in the design of clinical trials for molecularly targeted anticancer drugs as well as for the development of new biomarkers.
Full Text

Role of the gut microbiota in immunity and inflammatory disease
doi:10.1038/nri3430
Understanding the interaction of the microbiota with pathogens and the host might provide new insights into the pathogenesis of disease, as well as novel avenues for preventing and treating intestinal and systemic disorders.
Full Text

Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
doi:10.1038/nchembio.1223
Specific inhibitors of class IIa HDACs, based on a new zinc-binding scaffold, offer chemical probes to explore the biological function and potential druggability of this enzyme subclass.
Full Text

Drug Discovery
JOBS of the week
Research Associate - Compound Management
Novartis Institute for Tropical Diseases Pte Ltd, Singapore
Early Career Scientists and Engineers: Computational Biochemistry Research Group
D. E. Shaw Research
Bioinformatician (M / F)
German Cancer Research Center (DKFZ)
Post Doctoral Fellow
Aaron Diamond AIDS Research Center
Scientist in Neurodevelopmental Diseases
F. Hoffmann-La Roche AG
More Science jobs from
Drug Discovery
EVENT
Pediatric Drug Development
08.07.13
London, UK
More science events from

Careers

Top

Career snapshots archive
Career snapshots feature people associated with drug discovery and drug development, with the aim of providing expert insights and advice on a wide range of positions and career paths in this field.
Full Text

Top
Advertisement
SciBX: Science-Business eXchange is a weekly publication that identifies and analyzes the most important translational research articles from over 40 journals. Find out which papers have real scientific and commercial potential, and why.

Recommend SciBX to your library today.
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant)

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our customer feedback department

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments: